Search
Fosifidancitinib
go.drugbank.com/drugs/DB21462ExperimentalFosifidancitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Fosifidancitinib is a Janus kinase inhibitor.
Gemnelatinib
go.drugbank.com/drugs/DB21513ExperimentalGemnelatinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Gemnelatinib is a tyrosine kinase inhibitor.
Girocitinib
go.drugbank.com/drugs/DB21692ExperimentalGirocitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Girocitinib is a Janus kinase inhibitor.
Nedemelteon
go.drugbank.com/drugs/DB21700ExperimentalNedemelteon is a small molecule drug. The usage of the INN stem '-melteon' in the name indicates that Nedemelteon is a melatonin receptor agonist.
Panamesine
go.drugbank.com/drugs/DB19466ExperimentalPanamesine is a small molecule drug. The usage of the INN stem '-mesine' in the name indicates that Panamesine is a sigma receptor ligand. Panamesine has a monoisotopic molecular weight of 426.18 Da.
Cipemastat
go.drugbank.com/drugs/DB19468ExperimentalCipemastat is a small molecule drug. The usage of the INN stem '-mastat' in the name indicates that Cipemastat is a matrix metalloproteinase inhibitor.
Safotibant
go.drugbank.com/drugs/DB19469ExperimentalSafotibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Safotibant is a bradykinin receptor antagonist.
Azaloxan
go.drugbank.com/drugs/DB19540ExperimentalAzaloxan is a small molecule drug. The usage of the INN stem '-oxan(e)' in the name indicates that Azaloxan is a benzodioxane derivative. Azaloxan has a monoisotopic molecular weight of 331.19 Da.
Imirestat
go.drugbank.com/drugs/DB19544ExperimentalImirestat is a small molecule drug. The usage of the INN stem '-restat' in the name indicates that Imirestat is a aldose reductase inhibitor.
Tiamenidine
go.drugbank.com/drugs/DB19607ExperimentalTiamenidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Tiamenidine is a a2 adrenoreceptor agonist.